Semi-Reclimet Tablet

Semi-Reclimet 40mg/500mg Tablet

Semi-Reclimet 40mg/500mg Tablet is a combination anti-diabetic medicine manufactured and marketed by Dr Reddy’s Laboratories Ltd, formulated with Gliclazide 40mg and Metformin Hydrochloride 500mg in each tablet. Gliclazide belongs to the sulfonylurea class of medicines and works by stimulating the pancreas to release more insulin, while Metformin belongs to the biguanide class and works by reducing the amount of sugar produced by the liver, slowing sugar absorption from the gut, and improving the body’s sensitivity to insulin. Together, these two complementary mechanisms help lower blood sugar levels more effectively than either medicine alone, making Semi-Reclimet 40mg/500mg Tablet a widely used option for managing type 2 diabetes mellitus in adults, particularly when diet, exercise and a single medicine are not enough to keep blood sugar under control. Semi-Reclimet 40mg/500mg Tablet is usually taken with meals, as this helps improve absorption and reduces the chance of stomach upset, and it should be taken at the same time each day to maintain steady blood sugar control. The dose is individualised by the doctor based on blood sugar readings and response to treatment, and it should never be adjusted or stopped without medical advice, since doing so can lead to poorly controlled blood sugar or an episode of hypoglycaemia. Common effects that may be seen include nausea, stomach upset, loss of appetite and a metallic taste in the mouth, which usually settle as the body adjusts to the medicine. Because Semi-Reclimet 40mg/500mg Tablet can lower blood sugar significantly, patients should watch for signs of hypoglycaemia such as sweating, shakiness, dizziness or confusion, and should always carry a source of fast-acting sugar when going out.

Key Features

• Combination tablet with Gliclazide 40mg and Metformin Hydrochloride 500mg
• Manufactured and marketed by Dr Reddy’s Laboratories Ltd
• Combines two complementary mechanisms for more effective blood sugar control
• Used in the management of type 2 diabetes mellitus in adults
• Schedule H prescription drug, supplied as a strip of 10 tablets

Composition

• Gliclazide – 40 mg
• Metformin Hydrochloride – 500 mg

Uses & Benefits

• Helps control high blood sugar levels in type 2 diabetes
• Gliclazide stimulates the pancreas to release more insulin
• Metformin reduces sugar production by the liver and improves insulin sensitivity
• Combined action supports better overall blood sugar management
• Reduces the long-term risk of diabetes-related complications when used as advised
• Convenient two-in-one tablet reduces the number of medicines taken daily

Directions for Use

• Take exactly as prescribed by your doctor, in the dose and duration advised
• Take with meals to improve absorption and reduce stomach upset
• Take at the same time each day to maintain steady blood sugar levels
• Do not skip meals after taking this medicine, as this can cause low blood sugar
• Do not stop or change the dose without consulting your doctor

Precautions

• To be used strictly under medical supervision as a Schedule H prescription drug
• Watch for signs of low blood sugar such as sweating, shakiness, dizziness or confusion
• Inform your doctor if you have kidney, liver or heart problems
• Limit or avoid alcohol, as it can increase the risk of low blood sugar
• Blood sugar and kidney function should be monitored periodically during treatment
• Consult your doctor before use if pregnant or breastfeeding

Storage

• Store below 30°C in a cool, dry place, protected from light and moisture
• Keep out of reach and sight of children
• Do not use beyond the printed expiry date

Disclaimer: The information provided is for educational purposes and does not substitute professional medical advice. This is a Schedule H prescription drug to be used only under the guidance of a registered medical practitioner. Please consult your doctor before use.